17-beta-estradiol
Atrophic Vaginitis
University Hospital, GhentPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Atrophic Vaginitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Estriol ITF Research Pharma, S.L.U. | Phase 2 | BB |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →